Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer (original) (raw)

Profile image of Chiara CaparelloChiara Caparello

2017, Scientific Reports

visibility

description

8 pages

link

1 file

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy

Elin Richardsen

The Journal of Pathology: Clinical Research, 2021

View PDFchevron_right

Identification of susceptibility loci in a mouse model of KRASG12D-driven pancreatic cancer

Norman Drinkwater

2010

View PDFchevron_right

Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins

Margo Shoup

Gut, 2006

View PDFchevron_right

Genomic analysis of pancreatic cancer: a glimmer of hope for the therapy?

Andrea Galli

Translational Cancer Research, 2016

View PDFchevron_right

Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

Xingdi Ma

Cancer Discovery, 2020

View PDFchevron_right

Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer

Núria Malats

Journal of Epidemiology & Community Health, 2007

View PDFchevron_right

Novel Biomarkers in Pancreatic Cancer

Anca Botezatu

Pancreatic Cancer - Clinical Management, 2012

View PDFchevron_right

KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy

Simona Lamba

International Journal of Cancer, 2013

View PDFchevron_right

K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer

François Lefort

Gastroenterology, 1997

View PDFchevron_right

KRAS Mutant Status May Be Associated with Distant Recurrence in Early-stage Rectal Cancer

Savvas Papagrigoriadis

Anticancer Research, 2017

View PDFchevron_right

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

Pancreatic Cancer Cell DNA Content Correlates With Long-term Survival After Pancreatoduodenectomy

William Dooley

Annals of Surgery, 1991

View PDFchevron_right

Prognostic Value of Molecular Subtypes in Pancreatic Cancer

Emilie Mamessier

Pancreas, 2017

View PDFchevron_right

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

Giulia Siravegna

Nature, 2012

View PDFchevron_right

Kras g12d in colon cancer

Alberto Zaniboni

View PDFchevron_right

Mutations in KRAS: are they a valid biomarker for pancreatic ductal adenocarcinomas diagnosis?

Maikel Peppelenbosch

Translational Cancer Research, 2017

View PDFchevron_right

Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer

luis raez

Molecular Cancer Therapeutics, 2021

View PDFchevron_right

DNA sequences amplified in cancer cells: an interface between tumor biology and human genome analysis

Mordechai Gutman

Mutation Research/Reviews in Genetic Toxicology, 1992

View PDFchevron_right

Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

Simona Lamba

JAMA, 2010

View PDFchevron_right

Genetic Effects and Modifiers of Radiotherapy and Chemotherapy on Survival in Pancreatic Cancer

Dhanpat Jain

Pancreas, 2011

View PDFchevron_right

Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer

João Paulo

Nature Genetics, 2019

View PDFchevron_right

How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis

tomas lopez

European Journal of Clinical Investigation, 2011

View PDFchevron_right

A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma

William Dooley

Cancer, 1993

View PDFchevron_right

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer

L. Karayan-Tapon

Annals of Oncology, 2013

View PDFchevron_right

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients

Maria Ziembar

2011

View PDFchevron_right

Detection of K-ras mutations in lung carcinomas: Relationship to prognosis

Rodney Landreneau

Lung Cancer, 1996

View PDFchevron_right

Three Different Techniques for KRAS Mutational Analysis in EUS-FNA Pancreatic Lesions: Sanger Sequencing, Next Generation Sequencing and Real-Time PCR

paola baccarini

Journal of the Pancreas, 2012

View PDFchevron_right

New Targets for Therapy in Pancreatic Cancer

Michele Tursi

cdn.intechopen.com

View PDFchevron_right

P0089 Pancreatic Cancer and Glucose Metabolism

Kemal Rasa

European Journal of Internal Medicine, 2009

View PDFchevron_right

Overcoming diagnostic issues in precision treatment of pancreatic cancer

Rainer Heuchel

Expert review of precision medicine and drug development, 2018

View PDFchevron_right

Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer

Benjamin Cottam

JAMA surgery, 2018

View PDFchevron_right

Mutations of the Ki-ras oncogene in endometrial carcinoma

john mclachlan

American Journal of Obstetrics and Gynecology, 1992

View PDFchevron_right

Diagnostic Value of K-ras Mutations in Serum of Pancreatic Cancer Patients

Simon Bar Meir

Annals of the New York Academy of Sciences, 2006

View PDFchevron_right

Pancreatic Cancer - Insights into Molecular Mechanisms and Novel Approaches to Early Detection and Treatment

Kelly McCall

2014

View PDFchevron_right

Detection of KRAS mutations of colorectal cancer with peptide-nucleic-acid-mediated real-time PCR clamping

Chii-Wann Lin

Biotechnology & Biotechnological Equipment, 2016

View PDFchevron_right

Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors

Joseph Day

Oncogene, 1999

View PDFchevron_right

Medicine